LogoLogoMSF Science Portal
  • My saved items
logo

© Médecins Sans Frontières

MSF Science Portal
About MSF Science Portal
About MSF
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use

v2.1.4829.produseast1

3 result(s)
Filter and sort
3 result(s)
Journal Article > Case Report/SeriesFull Text

Delivery of an Ebola virus-positive stillborn infant in a rural community health center, Sierra Leone, January 2015

Am J Trop Med Hyg. 10 November 2015; Volume 94 (Issue 2); 417-9.; DOI:10.4269/ajtmh.15-0619
Bower H, Grass JE, Veltus E, Brault AC, Campbell S,  et al.
Am J Trop Med Hyg. 10 November 2015; Volume 94 (Issue 2); 417-9.; DOI:10.4269/ajtmh.15-0619
We report the case of an Ebola virus (EBOV) RNA-negative pregnant woman who delivered an EBOV RNA-positive stillborn infant at a community health center in rural Sierra Leone, 1 month after the mother's last possible exposure. The mother was later found to be immunoglobulins M and G positive indicating previous infection. The apparent absence of Ebola symptoms and not recognizing that the woman had previous contact with an Ebola patient led health workers performing the delivery to wear only minimal personal protection, potentially exposing them to a high risk of EBOV infection. This case emphasizes the importance of screening for epidemiological risk factors as well as classic and atypical symptoms of Ebola when caring for pregnant women, even once they have passed the typical time frame for exposure and incubation expected in nonpregnant adults. It also illustrates the need for health-care workers to use appropriate personal protection equipment when caring for pregnant women in an Ebola setting.More
Journal Article > ResearchFull Text

Prognostic Indicators for Ebola Patient Survival

Emerg Infect Dis. 1 February 2016; Volume 22 (Issue 2); 217-23.; DOI:10.3201/eid2202.151250
Crowe SJ, Maenner MJ, Kuah S, Erickson BR, Coffee M,  et al.
Emerg Infect Dis. 1 February 2016; Volume 22 (Issue 2); 217-23.; DOI:10.3201/eid2202.151250
To determine whether 2 readily available indicators predicted survival among patients with Ebola virus disease in Sierra Leone, we evaluated information for 216 of the 227 patients in Bo District during a 4-month period. The indicators were time from symptom onset to healthcare facility admission and quantitative real-time reverse transcription PCR cycle threshold (Ct), a surrogate for viral load, in first Ebola virus-positive blood sample tested. Of these patients, 151 were alive when detected and had reported healthcare facility admission dates and Ct values available. Time from symptom onset to healthcare facility admission was not associated with survival, but viral load in the first Ebola virus-positive blood sample was inversely associated with survival: 52 (87%) of 60 patients with a Ct of >24 survived and 20 (22%) of 91 with a Ct of <24 survived. Ct values may be useful for clinicians making treatment decisions or managing patient or family expectations.More
Journal Article > ResearchFull Text

Ebola Virus Epidemiology, Transmission, and Evolution during Seven Months in Sierra Leone

Cell. 18 June 2015; Volume 161 (Issue 7); DOI:10.1016/j.cell.2015.06.007
Park DJ, Dudas G, Wohl S, Goba A, Whitmer SL,  et al.
Cell. 18 June 2015; Volume 161 (Issue 7); DOI:10.1016/j.cell.2015.06.007
The 2013-2015 Ebola virus disease (EVD) epidemic is caused by the Makona variant of Ebola virus (EBOV). Early in the epidemic, genome sequencing provided insights into virus evolution and transmission and offered important information for outbreak response. Here, we analyze sequences from 232 patients sampled over 7 months in Sierra Leone, along with 86 previously released genomes from earlier in the epidemic. We confirm sustained human-to-human transmission within Sierra Leone and find no evidence for import or export of EBOV across national borders after its initial introduction. Using high-depth replicate sequencing, we observe both host-to-host transmission and recurrent emergence of intrahost genetic variants. We trace the increasing impact of purifying selection in suppressing the accumulation of nonsynonymous mutations over time. Finally, we note changes in the mucin-like domain of EBOV glycoprotein that merit further investigation. These findings clarify the movement of EBOV within the region and describe viral evolution during prolonged human-to-human transmission.More